Home > Cashflow Statement > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Cashflow Statement

BAFNA PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BAFNA PHARMACEUTICALS
Please provide your vote to see the results

BAFNA PHARMACEUTICALS Last 5 Year Cashflow Statement History

[Standalone]

Mar2026Mar2025Mar2024Mar2023Mar2022
Profit Before Tax₹11 Cr₹4.15 Cr₹7.35 Cr₹12 Cr₹5.19 Cr
Adjustment ₹9.68 Cr₹10 Cr₹7.59 Cr₹7.88 Cr₹5.50 Cr
Changes In working Capital ₹-5.60 Cr₹7.55 Cr₹-5.28 Cr₹-14 Cr₹-0.80 Cr
Cash Flow after changes in Working Capital ₹15 Cr₹22 Cr₹9.66 Cr₹5.08 Cr₹9.90 Cr
Cash Flow from Operating Activities ₹15 Cr₹22 Cr₹9.48 Cr₹4.95 Cr₹9.73 Cr
Cash Flow from Investing Activities ₹-22 Cr₹-21 Cr₹-15 Cr₹-7.49 Cr₹-6.54 Cr
Cash Flow from Financing Activities ₹5.62 Cr₹1.06 Cr₹-0.85 Cr₹10 Cr₹-4.81 Cr
Net Cash Inflow / Outflow ₹-1.41 Cr₹2.04 Cr₹-6.41 Cr₹7.64 Cr₹-1.63 Cr
Opening Cash & Cash Equivalents ₹3.43 Cr₹1.40 Cr₹7.81 Cr₹0.17 Cr₹1.80 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations -----
Closing Cash & Cash Equivalent ₹2.02 Cr₹3.43 Cr₹1.40 Cr₹7.81 Cr₹0.17 Cr

Compare Cashflow Statement of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹688.2 Cr 12% 10% 209.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹460,696.0 Cr 0.5% -4% 15.7% Stock Analytics
DIVIS LABORATORIES ₹246,063.0 Cr 9.1% 18.2% 47.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹191,515.0 Cr 3.6% 3.4% 36.4% Stock Analytics
CIPLA ₹114,554.0 Cr -1.2% -3.3% -10.8% Stock Analytics
DR REDDYS LABORATORIES ₹98,308.6 Cr -1.4% 2.9% -8% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

12%

10%

209.1%

SENSEX

-0.4%

-0.5%

-5.8%


You may also like the below Video Courses